Business Description
Insight Molecular Diagnostics, formerly OncoCyte Corporation, is a Nashville-based diagnostics company that develops and sells blood-based and gene expression tests for cancer monitoring, transplant care, and immunotherapy response prediction across the United States and internationally. Its cancer-focused tools help detect disease progression early in treatment, while its transplant monitoring tests measure donor DNA in the blood to track organ health following kidney and liver transplants. The company also supports clinical trials and biomarker research, and works with Bio-Rad Laboratories to bring certain diagnostic products to a wider market.
